IL1F10 and colorectal carcinoma: In the context of dysregulated intestinal mucosal immunity, particularly in chronic intestinal inflammation prone to the development of CRC (24), our findings are in line with a prior study indicating a correlation between IL-38 expression in CRC tissue and patient survival.